Literature DB >> 976316

Analysis of cardiac chronotropic responses to some autonomic blocking agents in conscious trained dogs.

I Cavero, H Riggenbach, M Wall, M Gerold.   

Abstract

The changes of heart rate in response to i.v. administration of methylatropine (0.5 mg/kg) and/or propranolol (2 mg/Kg) or practolol (2.5 mg/Kg) were studied in conscious trained dogs. Cholinergic blockade alone or combined blockade of sympathetic and parasympathetic effector systems resulted in cardiac acceleration. Conversely, beta-adrenoceptor antagonism with either propranolol or practolol reduced heart rate. The data were analysed by means of a new method, whereby the heart (HRN) of the dog is considered to be the product of the intrinsic heart rate (HR0) and 3 further factors: HRN-HR0 times S times V times W (Multiplicative model). 2 of these factors represent the tonic sympathetic (S) and parasympathetic (V) influences, whereas the third (W) represents the sympathetic-parasympathetic interaction. This type of analysis reveals that W was approximately 1, i.e., the sympathetic-parasympathetic interaction did not play any significant role in determining the heart rate of conscious resting dogs (HRN = HRO-S-V-W = HRO-S-V). The change of heart rate due to the action of parasympathetic system (-53% of the intrinsic heart rate) was more important than the change caused by the action of the sympathetic system (26% of the intrinsic heart rate).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976316     DOI: 10.1016/0014-2999(76)90127-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Central and peripheral contributions to control of heart rate during heat acclimation.

Authors:  M Horowitz; U Meiri
Journal:  Pflugers Arch       Date:  1993-01       Impact factor: 3.657

2.  Incomplete cardiac vagal blockade with atropine in the anesthetized dog.

Authors:  J R Brunsting; J H Bennekers; H A Schuil; W G Zijlstra
Journal:  Pflugers Arch       Date:  1979-09       Impact factor: 3.657

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.